Sensodyne

Pfizer To Sell €2.96bn Stake In Sensodyne Maker Haleon

Pfizer will sell shares worth £2.50 billion ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% fr...

Sensodyne-Maker Haleon Posts Unexpected Drop In Revenue On Weak Demand For Its Painkiller

Haleon posted an unexpected drop in third-quarter revenue, hurt by a weak demand for its painkiller in Australia and the Middle East.

Haleon Unveils Plan To Invest £130m New Innovation Centre For Oral Health

Consumer healthcare company Haleon has announced an investment of £130 million (€156 million) in a Global Oral Health Innovation Centre in Surre...

Haleon Forecasts High Single-Digit Growth For Annual Organic Operating Profit

Haleon has forecast high single-digit growth in organic operating profit in 2024, after reporting a 4% rise in half-year pre-tax earnings amid strong deman...

GSK Raises £1.25bn From Offloading Haleon Stake At A Discount

GSK has raised £1.25 billion (€1.46 billion). from selling its entire remaining stake in consumer healthcare firm Haleon, the British drugmaker...

Haleon Posts Tepid Q1 Sales As Demand For Some Products Cool Off

Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates as volumes declined.

Sensodyne-Maker Haleon To Shut UK Manufacturing Site, With More Than 400 Jobs Hit

Consumer healthcare company Haleon is planning to shut down its manufacturing site in Britain by 2026, which will impact 435 jobs, a spokesperson told Reut...